OMIM Search - 'Thalassemia',,,,,
Downloaded:,"Mar 12, 2016",,,,
"Copyright (c) 1966-2016 Johns Hopkins University OMIM, data are provided for research purposes only.",,,,,
,,,,,
MIM Number,Title,Included Titles,Cytogenetic Location,Genomic Coordinates (From NCBI/GRCh38),Entrez Gene ID
+141900,HEMOGLOBIN--BETA LOCUS; HBB,"METHEMOGLOBINEMIA, BETA-GLOBIN TYPE, INCLUDED;;ERYTHREMIA, BETA-GLOBIN TYPE, INCLUDED",11p15.4,11:5225465-5227070,3043
#613985,BETA-THALASSEMIA,,"11p15.4, 11p15.4",,
*141850,HEMOGLOBIN--ALPHA LOCUS 2; HBA2,,16p13.3,16:172846-173709,3040
+141800,HEMOGLOBIN--ALPHA LOCUS 1; HBA1,"METHEMOGLOBINEMIA, ALPHA-GLOBIN TYPE, INCLUDED;;ERYTHREMIA, ALPHA-GLOBIN TYPE, INCLUDED",16p13.3,16:176650-177521,3039
*142000,HEMOGLOBIN--DELTA LOCUS; HBD,,11p15.4,11:5232828-5234627,3045
#141749,FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HBFQTL1,"DELTA-BETA THALASSEMIA, INCLUDED","11p15.4, 11p15.4, 11p15.4",,
#301040,"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX",,Xq21.1,,
#141750,"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED",,16pter-p13.3,,
*300032,ATR-X GENE; ATRX,,Xq21.1,X:77504877-77786268,546
#613978,HEMOGLOBIN H DISEASE; HBH,"HEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED","16p13.3, 16p13.3",,
#603903,SICKLE CELL ANEMIA,,11p15.4,,
#314050,"THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT",,Xp11.23,,
#236750,"HYDROPS FETALIS, NONIMMUNE; NIHF","HYDROPS FETALIS, ALPHA-THALASSEMIA-RELATED, INCLUDED;;HEMOGLOBIN H HYDROPS FETALIS SYNDROME, INCLUDED",,,
#604131,ALPHA-THALASSEMIA,,"16p13.3, 16p13.3",,
#300448,ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME; ATMDS,,Xq21.1,,
#603902,"BETA-THALASSEMIA, DOMINANT INCLUSION BODY TYPE",,11p15.4,,
187550,"THALASSEMIA, BETA+, SILENT ALLELE",,,,
#309580,"MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1",,Xq21.1,,
#264800,PSEUDOXANTHOMA ELASTICUM; PXE,"PSEUDOXANTHOMA ELASTICUM, MODIFIER OF SEVERITY OF, INCLUDED;;PXE, MODIFIER OF SEVERITY OF, INCLUDED","16p13.11, 16p12.3, 17q21.33",,
*142200,"HEMOGLOBIN, GAMMA A; HBG1",,11p15.4,11:5248271-5249856,3047
*191740,"UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1","UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A GENE COMPLEX, INCLUDED; UGT1A, INCLUDED;;UGT1A GENE COMPLEX, INCLUDED",2q37.1,2:233760272-233773298,54658
#173900,POLYCYSTIC KIDNEY DISEASE 1; PKD1,"POLYCYSTIC KIDNEY DISEASE, ADULT, INCLUDED; APKD, INCLUDED;;POTTER TYPE III POLYCYSTIC KIDNEY DISEASE, INCLUDED",16p13.3,,
#611162,"MALARIA, SUSCEPTIBILITY TO","MALARIA, RESISTANCE TO, INCLUDED;;MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, SEVERE, RESISTANCE TO, INCLUDED;;MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;;MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED","1q23.2, 1q23.3, 1q23.3, 1q32.2, 2q14.3, 3p21.2, 4q31.21, 4q31.21, 6p21.33, 7q21.11, 11p15.4, 11q24.2, 17q11.2, 17q21.31, 19p13.2, Xq28",,
%142470,FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2; HBFQTL2,,6q22.3-q23.1,6:118100000-130900000,7954
*305371,GATA-BINDING PROTEIN 1; GATA1,,Xp11.23,X:48786559-48794310,2623
*187270,TELOMERASE REVERSE TRANSCRIPTASE; TERT,,5p15.33,5:1253166-1295046,7015
*613665,ATYPICAL CHEMOKINE RECEPTOR 1; ACKR1,,1q23.2,1:159204012-159206499,2532
#612653,"SPHEROCYTOSIS, TYPE 4; SPH4",,17q21.31,,
*142310,HEMOGLOBIN--ZETA LOCUS; HBZ,,16p13.3,16:142052-154504,3050
*605821,ERYTHROID-ASSOCIATED FACTOR; ERAF,,16p11.2,16:31527851-31528802,51327
#601675,"TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1",,19q13.32,,
*600599,KRUPPEL-LIKE FACTOR 1; KLF1,,19p13.13,19:12884421-12887202,10661
*126340,"EXCISION REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 2; ERCC2",,19q13.32,19:45351390-45370645,2068
*142250,"HEMOGLOBIN, GAMMA G; HBG2",,11p15.4,11:5253190-5254780,3048
*605312,GROWTH/DIFFERENTIATION FACTOR 15; GDF15,,19p13.11,19:18386157-18389175,9518
*606464,HEPCIDIN ANTIMICROBIAL PEPTIDE; HAMP,,19q13.12,19:35282506-35285142,57817
*120620,COMPLEMENT COMPONENT RECEPTOR 1; CR1,,1q32.2,1:207496127-207641764,1378
*152424,"LOCUS CONTROL REGION, BETA",,11p15.4,11:5275849-5291370,387281
#609057,NEPHROPATHY WITH PRETIBIAL EPIDERMOLYSIS BULLOSA AND DEAFNESS,,11p15.5,,
%142335,FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 5; HBFQTL5,,2p16.1,2:54700000-61000000,3247
*607782,"LUC7, S. CEREVISIAE, HOMOLOG OF; LUC7L",,16p13.3,16:188970-229449,55692
*152422,"LOCUS CONTROL REGION, ALPHA",,,,
+600046,"ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 1; ABCA1","CORONARY HEART DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA, PROTECTION AGAINST, INCLUDED;;HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 13, INCLUDED; HDLCQ13, INCLUDED",9q31.1,9:104781001-104928245,19
+609708,LIPOPROTEIN LIPASE; LPL,"HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 11, INCLUDED; HDLCQ11, INCLUDED",8p21.3,8:19939070-19967258,4023
#611804,ELLIPTOCYTOSIS 1; EL1,,1p35.3,,
#203100,"ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A",,11q14.3,,
#179620,RAPH BLOOD GROUP SYSTEM,,11p15.5,,
#607140,ANGIOID STREAKS,,,,
#278300,"XANTHINURIA, TYPE I",,2p23.1,,
%125480,MAJOR AFFECTIVE DISORDER 1; MAFD1,,18p,,4095
*139250,GROWTH HORMONE 1; GH1,,17q23.3,17:63917192-63918851,2688
*604653,"SOLUTE CARRIER FAMILY 40 (IRON-REGULATED TRANSPORTER), MEMBER 1; SLC40A1",,2q32.2,2:189560589-189580810,30061
*609806,HYDROXYMETHYLBILANE SYNTHASE; HMBS,,11q23.3,11:119084875-119093548,3145
*602243,CD151 ANTIGEN; CD151,,11p15.5,11:832951-838834,977
*604720,TRANSFERRIN RECEPTOR 2; TFR2,,7q22.1,7:100620415-100642764,7036
*602421,CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR,,7q31.2,7:117478339-117668664,1080
#133100,"ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1",,"9p24.1, 12q24.12, 19p13.2",,
#142309,HEMOGLOBIN--VARIANTS FOR WHICH THE CHAIN CARRYING THE MUTATION IS UNKNOWN OR UNCERTAIN,,,,
#231690,GLUTARIC ACIDURIA III,,7p14.1,,
#303700,BLUE CONE MONOCHROMACY; BCM,"CONE DYSTROPHY 5, X-LINKED, INCLUDED; COD5, INCLUDED","Xq28, Xq28",,
#300751,"ANEMIA, SIDEROBLASTIC, X-LINKED; XLSA",,Xp11.21,,
#300653,PHOSPHOGLYCERATE KINASE 1 DEFICIENCY,,Xq21.1,,
#166200,"OSTEOGENESIS IMPERFECTA, TYPE I; OI1",,17q21.33,,
#201910,"ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY","HYPERANDROGENISM, NONCLASSIC TYPE, DUE TO 21-HYDROXYLASE DEFICIENCY, INCLUDED",6p21.33,,
#613490,ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD,,14q32.13,,
#229800,"FRUCTOSURIA, ESSENTIAL",,2p23.3,,
#224100,"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE II; CDAN2",,20p11.23,,
#115200,"CARDIOMYOPATHY, DILATED, 1A; CMD1A",,1q22,,
#105830,ANGELMAN SYNDROME; AS,"ANGELMAN SYNDROME CHROMOSOME REGION, INCLUDED; ANCR, INCLUDED",15q11.2,,
#180849,RUBINSTEIN-TAYBI SYNDROME 1; RSTS1,,16p13.3,,
#182900,"SPHEROCYTOSIS, TYPE 1; SPH1",,8p11.21,,
%237800,"HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB",,,,
%172150,6-PHOSPHOGLUCONOLACTONASE DEFICIENCY,,,,
*612602,RNA-BINDING MOTIF PROTEIN 15B; RBM15B,,3p21.2,3:51391267-51397907,29890
*613018,TYROSINE AMINOTRANSFERASE; TAT,,16q22.2,16:71566850-71577094,6898
*141860,HEMOGLOBIN--ALPHA LOCUS 3,,,,
*142240,HEMOGLOBIN--THETA-1 LOCUS; HBQ1,,16p13.3,16:180333-181178,3049
*305900,GLUCOSE-6-PHOSPHATE DEHYDROGENASE; G6PD,,Xq28,X:154531389-154547585,2539
*300746,COAGULATION FACTOR IX; F9,,Xq27.1,X:139530733-139563463,2158
*300401,PROTEOLIPID PROTEIN 1; PLP1,"DM20, INCLUDED",Xq22.2,X:103776505-103792618,5354
*300658,NDP GENE; NDP,,Xp11.3,X:43948775-43973674,4693
*301300,DELTA-AMINOLEVULINATE SYNTHASE 2; ALAS2,,Xp11.21,X:55009054-55031063,212
*300005,METHYL-CpG-BINDING PROTEIN 2; MECP2,,Xq28,X:154021812-154097730,4204
*606935,RNA-BINDING MOTIF PROTEIN 17; RBM17,,10p15.1,10:6088985-6117458,84991
*605923,SRY-BOX 8; SOX8,,16p13.3,16:981807-986978,30812
*264900,COAGULATION FACTOR XI; F11,,4q35.2,4:186265944-186289680,2160
*601861,REGULATORY FACTOR X-ASSOCIATED PROTEIN; RFXAP,,13q13.3,13:36819201-36829602,5994
*609712,"PYRUVATE KINASE, LIVER AND RED BLOOD CELL; PKLR",,1q22,1:155289292-155308708,5313
*111680,"RHESUS BLOOD GROUP, D ANTIGEN; RHD",,1p36.11,1:25272392-25330444,6007
*606829,FRATAXIN; FXN,,9q21.11,9:69035562-69100177,2395
*606869,HEXOSAMINIDASE A; HEXA,,15q23,15:72343436-72376178,3073
*107400,"SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 1; SERPINA1",,14q32.13,14:94376746-94390691,5265
*150200,CHORIONIC SOMATOMAMMOTROPIN HORMONE 1; CSH1,,17q23.3,17:63894907-63896660,1442
*182860,"SPECTRIN, ALPHA, ERYTHROCYTIC 1; SPTA1",,1q23.1,1:158610497-158686715,6708